Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth I Berger

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
European Respiratory Review : an Official Journal of the European Respiratory Society|February 10, 2022
Clinical significance and applications of oscillometryDavid A Kaminsky, Shannon J Simpson, Kenneth I Berger, et al.
Genetics in Medicine Open|January 19, 2026
Expert opinion on facilitating intrafamily communication in rare diseases-Lessons from Fabry diseaseDominique P Germain, Fatma Al-Jasmi, Gheona Altarescu, et al.
Orphanet Journal of Rare Diseases|June 15, 2019
Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidanceMehmet Umut Akyol, Tord D Alden, Hernan Amartino, et al.
Orphanet Journal of Rare Diseases|May 31, 2019
Recommendations for the management of MPS VI: systematic evidence- and consensus-based guidanceMehmet Umut Akyol, Tord D Alden, Hernan Amartino, et al.
JAMA Neurology|April 10, 2023
Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks: A Phase 3 Randomized Clinical TrialPriya S Kishnani, Jordi Diaz-Manera, Antonio Toscano, et al.
The Lancet. Neurology|November 20, 2021
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trialJordi Diaz-Manera, Priya S Kishnani, Hani Kushlaf, et al.
American Journal of Respiratory and Critical Care Medicine|September 7, 2023
Lower Airway Dysbiosis Augments Lung Inflammatory Injury in Mild-to-Moderate Chronic Obstructive Pulmonary DiseaseImran Sulaiman, Benjamin G Wu, Matthew Chung, et al.
Journal of the American Medical Informatics Association : JAMIA|February 17, 2021
Enabling a learning healthcare system with automated computer protocols that produce replicable and personalized clinician actionsAlan H Morris, Brian Stagg, Michael Lanspa, et al.
Journal of the American Medical Informatics Association : JAMIA|September 20, 2022
Computer clinical decision support that automates personalized clinical care: a challenging but needed healthcare delivery strategyAlan H Morris, Christopher Horvat, Brian Stagg, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
European Respiratory Review : an Official Journal of the European Respiratory Society|February 10, 2022
Clinical significance and applications of oscillometryDavid A Kaminsky, Shannon J Simpson, Kenneth I Berger, et al.
Genetics in Medicine Open|January 19, 2026
Expert opinion on facilitating intrafamily communication in rare diseases-Lessons from Fabry diseaseDominique P Germain, Fatma Al-Jasmi, Gheona Altarescu, et al.
Orphanet Journal of Rare Diseases|June 15, 2019
Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidanceMehmet Umut Akyol, Tord D Alden, Hernan Amartino, et al.
Orphanet Journal of Rare Diseases|May 31, 2019
Recommendations for the management of MPS VI: systematic evidence- and consensus-based guidanceMehmet Umut Akyol, Tord D Alden, Hernan Amartino, et al.
JAMA Neurology|April 10, 2023
Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks: A Phase 3 Randomized Clinical TrialPriya S Kishnani, Jordi Diaz-Manera, Antonio Toscano, et al.
The Lancet. Neurology|November 20, 2021
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trialJordi Diaz-Manera, Priya S Kishnani, Hani Kushlaf, et al.
American Journal of Respiratory and Critical Care Medicine|September 7, 2023
Lower Airway Dysbiosis Augments Lung Inflammatory Injury in Mild-to-Moderate Chronic Obstructive Pulmonary DiseaseImran Sulaiman, Benjamin G Wu, Matthew Chung, et al.
Journal of the American Medical Informatics Association : JAMIA|February 17, 2021
Enabling a learning healthcare system with automated computer protocols that produce replicable and personalized clinician actionsAlan H Morris, Brian Stagg, Michael Lanspa, et al.
Journal of the American Medical Informatics Association : JAMIA|September 20, 2022
Computer clinical decision support that automates personalized clinical care: a challenging but needed healthcare delivery strategyAlan H Morris, Christopher Horvat, Brian Stagg, et al.
Pageof 11